idenix pharmaceuticals inc
(IDIX:Consolidated Issue Listed on NASDAQ Global Select )
Eugene R. Schiff M.D., F.A.C.P., F.R.C.P., M.A.C.G.
Member of Hepatitis Scientific Advisory Board, Idenix Pharmaceuticals Inc.
|Age||Total Calculated Compensation||This person is connected to 54 board members in 2 different organizations across 5 different industries.|
See Board Relationships
Dr. Eugene R. Schiff, M.D., FACP, FRCP, MACG is Professor of Medicine, Chief of the Division of Hepatology, and Director of the Center for Liver Diseases at the University of Miami School of Medicine in Miami, Florida. Dr. Schiff served as Director of Scientific and Development Advisory Board at Maxim Pharmaceuticals, Inc. since February 6, 2003. He serves as a Member of the Hepatitis Scientific Advisory Board of Idenix Pharmaceuticals Inc. He serves as a Member of Scientific ...
320 Bent StreetPhone: 617-995-9800
Cambridge, Massachusetts 02141
Board Members Memberships*There is no Board Members Memberships data available.
American College of Gastroenterology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|2.9M GBP||Compensation as of Fiscal Year 2013.|